- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01307787
Effects of a Rehabilitation Program on Physical Performance and Disease Self-management in Rheumatoid Arthritis.
January 21, 2022 updated by: University Medical Center Groningen
Effects of a Group-based Exercise and Educational Program on Physical Performance and Disease Self-management in Rheumatoid Arthritis: a Randomized Controlled Study
The purpose of this study is to evaluate the effects of a group-based exercise and educational program for people with Rheumatoid Arthritis (RA) on physical performance and disease-self-management.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Currently, the effectiveness of a program consisting of education to improve disease self-management combined with intensive exercises is not clear.
In the present study the investigators developed a group-based program for people with RA consisting of physical exercise to increase physical performance (i.e.
aerobic capacity and muscle strength) combined with an educational program to improve disease self-management (self-reported health status and self-efficacy).
The investigators called it the 'FIT program'.
The aim of the present randomized controlled trial (RCT) was to examine the effects of the FIT program on aerobic capacity, muscle strength, self-reported health status and self-efficacy, in a population of people with RA.
The investigators hypothesized that the FIT-program would have beneficial effects on physical performance (ie.
aerobic capacity and muscle strength) and disease self-management (i.e.
perceived health status and self-efficacy components) compared to a waiting list control group (WLCgroup).
Study Type
Interventional
Enrollment (Actual)
34
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Groningen
-
Haren, Groningen, Netherlands, PO box 30 002
- University Medical Center Groningen, Center for Rehabilitation
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 66 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- medical diagnosis of RA according to the American College of Rheumatology (ACR) criteria
- between 18 and 66 years of age
Exclusion Criteria:
- severe disease activity (Disease Activity Score:DAS-28 > 5.1)
- cardiac or pulmonary diseases resulting in restrictions in their ability to follow a physical exercise program
- a Steinbrocker classification of functional capacity in RA ≥ 3
- no stable medication for the RA
- intra-articular injections during the time of the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: fit-program
Participants in the intervention group followed an eight week multi-disciplinary group rehabilitation program, consisting of a physical exercise part and an educational component.
|
Participants in the intervention group followed an eight week multi-disciplinary group rehabilitation program, consisting of a physical exercise part and an educational component.
The physical exercise part consisted of a muscle exercise circuit and bicycle training,sport and aqua jogging.
The educational part consisted of a weekly sixty minutes session.
A multi-disciplinary group of healthcare professionals gave specialist orientated informational advice about how to handle the consequences of RA.
Special attention was paid to ensure adjusting the level of each patients activity level to the participants' actual energy level.
Further information was given about body sensations, sports, food and energy, pain, fatigue, emotional changes, sleeping disturbance and daily routine.
Other Names:
|
|
Other: waiting list control group
The waiting-list control group was allowed to enter the FIT program for rehabilitation after the study period.
|
waiting list control group with no intervention
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in VO2 Max, Maximum Oxygen Uptake in ml/Min/kg is the Standard Index of Cardio-respiratory Fitness
Time Frame: baseline, postintervention at 9 weeks
|
maximum oxygen uptake(VO2max, in ml/min/kg)was determined using the Åstrand-Rhyming test.The workload on the cycle ergometer was increased every minute by 25 watts until a steady-state heart rate was achieved.
Participants had to sustain cycling for about 6 minutes, the heart rate(HR) was taken every minute.
Mean HR of the 5th and 6th minute was registered.
With the given workload, observed HR and participants'weight, maximal oxygen uptake can be established using the Åstrand-Rhyming nomogram.
Values vary from < 21( sedentary with disease) to > 57 ( very good physical condition).
|
baseline, postintervention at 9 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Self-efficacy Pain and Other Symptoms
Time Frame: baseline, postintervention at 9 weeks,
|
Self-efficacy was assessed by the Arthritis-Self-efficacy Scale Dutch version.
This arthritis self-efficacy scale contains two sub scales: self-efficacy pain (5 items related to coping with pain, and self-efficacy other symptoms (6 items related to coping with other symptoms, such as depression, fatigue and frustrations.A five-point ordinal scale is used ranging from 'totally disagree' (1) to 'totally agree' (5).
We computed a mean score of 11 items ranging from 1-5.
A higher score refers to higher self-efficacy.
|
baseline, postintervention at 9 weeks,
|
|
Change in Self-efficacy Function
Time Frame: baseline, postintervention at 9 weeks,
|
Self-efficacy function was assessed by the Arthritis-Self-efficacy Scale Dutch version The subscale self-efficacy function contains 8 items related to physical function.
A five-point ordinal scale is used ranging from 'totally disagree' (1) to 'totally agree' (5).
A mean score of 8 items was computed ranging from 1-5.
A higher score refers to higher self-efficacy.
|
baseline, postintervention at 9 weeks,
|
|
Change in Muscle Strength of the Upper Extremity
Time Frame: baseline, postintervention at 9 weeks,
|
Muscle strength was assessed using a hand-held dynamometer (Microfet, Hoggan health Industries Inc.USA).Maximal voluntary isometric muscle strength of the elbow-flexors, elbow-extensors, was tested and recorded three times for each muscle group.
All tests were performed bilaterally.
The mean value of three measurements was computed.
In addition a sum score of the mean values of the flexors and extensors on both sides for the upper extremity (UE)was computed and taken for analyses.
|
baseline, postintervention at 9 weeks,
|
|
Change in Muscle Strength of the Lower Extremity
Time Frame: baseline, postintervention at 9 weeks,
|
Muscle strength was assessed using a hand-held dynamometer (Microfet, Hoggan health Industries Inc.USA).Maximal voluntary isometric muscle strength of the knee-flexor and knee-extensors, was tested and recorded three times for each muscle group.
All tests were performed bilaterally.
The mean value of three measurements was computed.
In addition a sum score of the mean values of the flexors and extensors on both sides for the lower extremity (LE)was computed and taken for analyses.
|
baseline, postintervention at 9 weeks,
|
|
Change in Health Status: Physical Health
Time Frame: baseline, postintervention at 9 weeks,
|
Self-reported health status was assessed using the Arthritis Impact-Measurement Scale-2, the Dutch version (Dutch-AIMS2).The questionnaire contains 77 items which represent 5 dimensions: physical functioning, psychological functioning, symptoms, social interaction and role functioning.
Responses are recorded on a 5-point scale.
All responses were recoded and calculated to a 0-10 scale.
Scores were modified according to the number of co-morbidity complaints, as was recommended in the Dutch-AIMS2 manual.
A low score indicates better health.
|
baseline, postintervention at 9 weeks,
|
|
Change in Health Status: Psychological Health
Time Frame: baseline, postintervention at 9 weeks,
|
Self-reported health status was assessed using the Arthritis Impact-Measurement Scale-2, the Dutch version (Dutch-AIMS2).The questionnaire contains 77 items which represent 5 dimensions: physical functioning, psychological functioning, symptoms, social interaction and role functioning.
Responses are recorded on a 5-point scale.
All responses were recoded and calculated to a 0-10 scale.
Scores were modified according to the number of co-morbidity complaints, as was recommended in the Dutch-AIMS2 manual.
A low score indicates better health.
|
baseline, postintervention at 9 weeks,
|
|
Change in Health Status: Social Interaction
Time Frame: baseline, postintervention at 9 weeks,
|
Self-reported health status was assessed using the Arthritis Impact-Measurement Scale-2, the Dutch version (Dutch-AIMS2).The questionnaire contains 77 items which represent 5 dimensions: physical functioning, psychological functioning, symptoms, social interaction and role functioning.
Responses are recorded on a 5-point scale.
All responses were recoded and calculated to a 0-10 scale.
Scores were modified according to the number of co-morbidity complaints, as was recommended in the Dutch-AIMS2 manual.
A low score indicates better health.
|
baseline, postintervention at 9 weeks,
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Ellen van Weert, phd, UMCG
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2005
Primary Completion (Actual)
May 1, 2007
Study Completion (Actual)
May 1, 2007
Study Registration Dates
First Submitted
March 2, 2011
First Submitted That Met QC Criteria
March 2, 2011
First Posted (Estimate)
March 3, 2011
Study Record Updates
Last Update Posted (Actual)
January 28, 2022
Last Update Submitted That Met QC Criteria
January 21, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 210.076
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rheumatoid Arthritis
-
Janssen Research & Development, LLCWithdrawnActive Rheumatoid Arthritis; Rheumatoid Arthritis
-
Centocor, Inc.CompletedRheumatoid Arthritis, Juvenile
-
Yuanyuan ZhangRecruitingRheumatoid Arthritis (RA) | Rheumatoid Arthritis-Associated Interstitial Lung Disease | Difficult-to-Treat Rheumatoid ArthritisChina
-
AmgenTerminated
-
Children's Hospital Medical Center, CincinnatiNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedJuvenile Rheumatoid ArthritisUnited States
-
AmgenImmunex CorporationCompletedJuvenile Rheumatoid Arthritis
-
Richard Burt, MDTerminated
-
Assistance Publique - Hôpitaux de ParisSociete Francaise de RhumatologieRecruiting
-
University Hospital, ToulouseCompletedRheumatoId ArthritisFrance
-
Amsterdam UMC, location VUmcEuropean CommissionCompletedRheumatoId ArthritisNetherlands, Germany, Portugal, Italy, Hungary, Romania, Slovakia
Clinical Trials on experimental Fit-program
-
VA Office of Research and DevelopmentTerminatedHearing LossUnited States
-
University of California, San FranciscoAmerican Cancer Society, Inc.; Kaiser PermanenteCompleted
-
Western University, CanadaCompletedObesity | OverweightCanada
-
Université de SherbrookeCompletedObesity, Childhood | Lifestyle Intervention | Preconception CareCanada
-
University of AlbertaUniversity of CalgaryActive, not recruitingPostoperative Complications | Surgery | MobilityCanada
-
University of BarcelonaCatSalut Catalonia, SpainCompletedCardiovascular Risk | Obesity Prevention | Non-communicable Diseases (NCD)Spain
-
Massachusetts General HospitalNational Institute on Aging (NIA)Completed
-
Sint MaartenskliniekCompletedAmputation | Lower Limb AmputationNetherlands
-
Western University, CanadaCanadian Institutes of Health Research (CIHR); Public Health Agency of Canada...CompletedObesity | OverweightCanada, United States
-
Burdur Mehmet Akif Ersoy UniversityCompletedAlzheimer Disease | Aging | Cognitive DeclineTurkey (Türkiye)